price
EO
NASDAQ · EOLS
Evolus, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$8.88
Up+$0.00 (+0.00%)
Updated Aug 31, 2026, 12:58 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 448.23M
- P/E ratio
- -7.64
- Dividend yield
- 0.00%
- 52-week range
- $3.86 – $9.12
- Volume
- 1.06M
- Avg. volume
- 1.3M
Price performance
EOLS price history
1M range · 20 trading sessions · Daily adjusted prices
EOLS closed at $8.88 after 20 trading sessions, up 46.78% for the selected period.
- Last close
- $8.88
- Period change
- +46.78%
- Period low
- $6.05
- Period high
- $8.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $8.84 | $8.94 | $8.595 | $8.88 | 1.06M |
| Aug 27, 2026 | $8.78 | $9.035 | $8.60 | $8.88 | 1.19M |
| Aug 26, 2026 | $8.86 | $9.08 | $8.77 | $8.78 | 1.51M |
| Aug 25, 2026 | $8.72 | $9.12 | $8.70 | $8.975 | 1.8M |
| Aug 24, 2026 | $8.39 | $8.82 | $8.2596 | $8.78 | 1.32M |
| Aug 21, 2026 | $8.35 | $8.48 | $8.235 | $8.39 | 582.72K |
| Aug 20, 2026 | $8.55 | $8.55 | $8.32 | $8.35 | 663.32K |
| Aug 19, 2026 | $8.22 | $8.69 | $8.22 | $8.60 | 964K |
| Aug 18, 2026 | $7.81 | $8.265 | $7.81 | $8.18 | 710.44K |
| Aug 17, 2026 | $8.13 | $8.2312 | $7.72 | $7.77 | 614.48K |
| Aug 14, 2026 | $8.02 | $8.258 | $7.91 | $8.155 | 648.72K |
| Aug 13, 2026 | $8.11 | $8.335 | $8.00 | $8.02 | 778.37K |
| Aug 12, 2026 | $8.24 | $8.35 | $8.07 | $8.12 | 959.13K |
| Aug 11, 2026 | $7.68 | $8.43 | $7.55 | $8.34 | 2.79M |
| Aug 10, 2026 | $7.465 | $7.64 | $7.18 | $7.57 | 1.4M |
| Aug 7, 2026 | $7.28 | $7.80 | $7.21 | $7.59 | 1.63M |
| Aug 6, 2026 | $6.99 | $7.52 | $6.54 | $7.41 | 2.92M |
| Aug 5, 2026 | $6.13 | $6.235 | $6.02 | $6.18 | 1.16M |
| Aug 4, 2026 | $6.10 | $6.18 | $5.93 | $6.12 | 668.34K |
| Aug 3, 2026 | $5.91 | $6.06 | $5.835 | $6.05 | 587.03K |
Latest EOLS news
The latest Smart Investors Daily articles mentioning EOLS.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…